Scientists discover a new way a disease-linked protein comes apart
Transthyretin amyloid disease (ATTR) is a progressive, life-threatening condition caused when the protein transthyretin (TTR) breaks apart and aggregates in the heart and other organs. One of the most common treatments, a drug called tafamidis, works by helping TTR stay intact—slowing how it normally unfolds and aggregates.
Phys.org
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from Phys.org.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
Phys.org (phys.org), a Tier B publisher, filed this report on . CurrentWire published this page 20 minutes later, on .
Signal breakdown
CurrentWire ranked this story 63.2 of 100 in the snapshot this page was rendered from.
- Freshness
- 33.7 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 8 of 10
- Velocity
- 0 of 5
Strongest signal: freshness, 33.7 of 35. How each signal is calculated.
Filed under Science · International · News.
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.